Literature DB >> 22302315

Campylobacter fetus infection in three rheumatoid arthritis patients treated with rituximab.

Alain Meyer, Arnaud Theulin, Emmanuel Chatelus, Xavier Argemi, Christelle Sordet, Rose Marie Javier, Yves Hansmann, Jean Sibilia, Jacques-Eric Gottenberg.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22302315     DOI: 10.1136/annrheumdis-2011-200719

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  6 in total

Review 1.  A comprehensive review of rituximab therapy in rheumatoid arthritis patients.

Authors:  Soheil Tavakolpour; Samira Alesaeidi; Mohammad Darvishi; Mojtaba GhasemiAdl; Sahar Darabi-Monadi; Meisam Akhlaghdoust; Somayeh Elikaei Behjati; Arash Jafarieh
Journal:  Clin Rheumatol       Date:  2019-08-01       Impact factor: 2.980

2.  A Case of Campylobacter Fetus Subspecies Fetus Systemic Infection.

Authors:  Pabitra Adhikari; Drashti Antala; Birat Bhandari; Khalid Mohamed; Goar Egoryan; Jonathan J Stake; Harvey Friedman
Journal:  Cureus       Date:  2022-04-08

3.  Campylobacter prosthetic joint infection.

Authors:  Shawn Vasoo; Jeramy J Schwab; Scott A Cunningham; Trisha J Robinson; Joseph R Cass; Elie F Berbari; Randall C Walker; Douglas R Osmon; Robin Patel
Journal:  J Clin Microbiol       Date:  2014-02-12       Impact factor: 5.948

4.  Early Onset Prosthetic Joint Infection and Bacteremia due to Campylobacter fetus Subspecies fetus.

Authors:  Igor Dumic; Mohan Sengodan; Joni J Franson; Diego Zea; Poornima Ramanan
Journal:  Case Rep Infect Dis       Date:  2017-08-08

5.  Myositis Ossificans of the Hip Due to Pyogenic Arthritis Caused by Campylobacter fetus Subspecies fetus.

Authors:  Sho Nishiguchi; Ichiro Sekine; Shun Kuroda; Morihiko Sato; Izumi Kitagawa
Journal:  Intern Med       Date:  2017-04-15       Impact factor: 1.271

6.  Prosthetic hip joint infection caused by Campylobacter fetus: A case report and literature review.

Authors:  M J Zamora-López; P Álvarez-García; M García-Campello
Journal:  Rev Esp Quimioter       Date:  2018-01-31       Impact factor: 1.553

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.